Amedisys La Acquisitions L L C is categorized under Home Health Care Services in Metairie, LA .
Amedisys La Acquisitions L L C was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 621610 by the NAICS.
If you are seeking more information, feel free to contact Brian Chehardy at the company’s branch by writing to 3501 North Causeway Boulevard # 225, Metairie, Louisiana LA 70002 or by phoning (504) 838-7080. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amedisys La Acquisitions L L C |
| Contact Person: | Brian Chehardy |
| Address: | 3501 North Causeway Boulevard # 225, Metairie, Louisiana 70002 |
| Phone Number: | (504) 838-7080 |
| Website Address: | amedisys.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 621610 |
| Share This Business: |
Amedisys La Acquisitions L L C was started in 0 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 621610. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Brian Chehardy for inquiries that concern Amedisys La Acquisitions L L C by calling the company number (504) 838-7080, as your correspondence is most welcome. Additionally, the physical location of the branch of Amedisys La Acquisitions L L C can be found at the coordinates 30.012714,-90.154532 as well as the street address 3501 North Causeway Boulevard # 225 in Metairie, Louisiana 70002.
For its online presence, you may visit Amedisys La Acquisitions L L C’s website at amedisys.com and engage with its social media outlets through on Twitter and on Facebook.